Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3.185 JPY | -1,09% | -12,86% | +3,07% |
08/05 | Japanse aandelen kleuren rood door winstnemingen en onzekerheid over renteverlagingen in de VS | MT |
04/01 | Kissei Pharmaceutical koopt 251 miljoen yen aan aandelen terug in december 2023 | MT |
Vakgebied
Aantal werknemers: 1 359
Verkoop per activiteit
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals
83,3
%
| 54 147 | 82,8 % | 56 243 | 83,3 % | +3,87% |
Information Service
12,3
%
| 7 742 | 11,8 % | 8 285 | 12,3 % | +7,01% |
Construction Contract
3,5
%
| 2 948 | 4,5 % | 2 343 | 3,5 % | -20,52% |
Goods
0,9
%
| 543 | 0,8 % | 621 | 0,9 % | +14,36% |
Verkoop per regio
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
100,0
%
| 65 381 | 100,0 % | 67 493 | 100,0 % | +3,23% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mutsuo Kanzawa
CEO | Chief Executive Officer | 74 | 31-03-76 |
Director of Finance/CFO | 62 | 01-04-86 | |
Yasuo Takehana
PSD | President | 63 | 01-04-84 |
Shinji Kikuchi
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-04-88 |
Suminori Sagara
BRD | Director/Board Member | 65 | 01-04-82 |
Director/Board Member | 65 | 01-04-83 | |
Tetsu Takayama
BRD | Director/Board Member | 62 | 01-04-85 |
Keiji Fukushima
BRD | Director/Board Member | 68 | 01-04-79 |
Yoshio Furihata
BRD | Director/Board Member | 62 | 01-04-84 |
Masaki Morozumi
BRD | Director/Board Member | 68 | 01-04-80 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mutsuo Kanzawa
CEO | Chief Executive Officer | 74 | 31-03-76 |
Hiroe Sato
BRD | Director/Board Member | 72 | 01-04-75 |
Masaki Morozumi
BRD | Director/Board Member | 68 | 01-04-80 |
Yoshio Furihata
BRD | Director/Board Member | 62 | 01-04-84 |
Masayuki Isaji
AUD | Comptroller/Controller/Auditor | 69 | 01-04-80 |
Keiji Fukushima
BRD | Director/Board Member | 68 | 01-04-79 |
Tetsu Takayama
BRD | Director/Board Member | 62 | 01-04-85 |
Shinji Kikuchi
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-04-88 |
Minoru Nomura
BRD | Director/Board Member | 77 | 01-06-16 |
Suminori Sagara
BRD | Director/Board Member | 65 | 01-04-82 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 49 311 185 | 32 265 747 ( 65,43 %) | 5 105 798 ( 10,35 %) | 65,43 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
CG ONCOLOGY, INC. 5.33% | 3 543 533 | 5.33% | 155 561 099 $ |
ALTEOGEN INC. 1.81% | 957 590 | 1.81% | 140 410 972 $ |
5 105 798 | 10.35% | 119 257 298 $ | |
SHIONOGI & CO., LTD. 0.36% | 1 077 000 | 0.36% | 55 150 488 $ |
DAIICHI SANKYO CO., LTD. 0.09% | 1 734 000 | 0.09% | 54 731 369 $ |
2 860 000 | 0.57% | 46 383 223 $ | |
4 918 000 | 3.79% | 27 913 437 $ | |
THE HACHIJUNI BANK, LTD. 0.64% | 3 276 402 | 0.64% | 22 514 517 $ |
2 000 000 | 0.82% | 15 355 640 $ | |
SUZUKEN CO., LTD. 0.59% | 461 560 | 0.59% | 14 147 654 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,07% | 915 mln. | |
+7,91% | 72,94 mld. | |
+12,64% | 9,06 mld. | |
-10,56% | 5,07 mld. | |
+58,79% | 4,78 mld. | |
+4,07% | 3,9 mld. | |
-16,90% | 2,56 mld. | |
+20,84% | 2,42 mld. | |
-26,13% | 2,39 mld. | |
+19,31% | 2,18 mld. |
- Beurs
- Aandelen
- Koers 4547
- Onderneming Kissei Pharmaceutical Co., Ltd.